Worth reading
57In focus
Scored from 1 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Financial results presentation2025年6月期 第2四半期2 items taken from the company’s own explanation
What the company explained in this material
New initiatives
子会社再編に伴うパートナーシップの検討Key KPIsA metric the company considers important as a management benchmark.
核酸抽出試薬・消耗品の販売実績。ただし数値は本文で確認できない| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | 2025年6月期 第2四半期 |
| Key KPIs | 核酸抽出試薬・消耗品の販売実績。ただし数値は本文で確認できない |
| New initiatives | 子会社再編に伴うパートナーシップの検討 |
Items this document does not state (27)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.資料では、PSSプラットフォームの拡大、核酸抽出試薬・消耗品の販売、子会社再編に伴うパートナーシップ検討などを戦略的推進テーマとして説明しているが、通期予想を修正した具体的な理由は記載されていない。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.